Thymalin: A Tracking Guide for an Older-Population Immune Peptide

Thymalin is a thymus-derived peptide complex with a long research history in Russian gerontology, most associated with Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology. Most of the published work is in Russian-language journals and focuses on immune regulation in older adults. Outside that body of literature, evidence is thin. If you choose to track it, treat it as exploratory.

What it does

Thymalin is a polypeptide fraction extracted from calf thymus. In the Khavinson literature it is described as a "bioregulator" affecting T-cell maturation, cytokine balance, and certain markers of immunosenescence. Reported clinical contexts include recovery after acute illness, chronic infection, and age-related immune decline.

The translational evidence outside the original research group is limited. That is the honest framing.

Typical protocol shape

Reported patterns in the literature and self-experimenter logs:

• Short courses — often 5 to 10 consecutive days, repeated 2 to 4 times per year
• Intramuscular administration in the original clinical work; some self-experimenters use SC
• Reconstituted with bacteriostatic water or saline depending on source

This is not a continuous daily protocol like BPC-157. It is closer to a seasonal course.

What to track daily

During a short course, log every day:

• Dose, route, site
• Subjective energy (1 to 10)
• Sleep quality and total hours
• Any signs of acute illness (sore throat, fatigue, low-grade fever)
• Mood and cognitive clarity
• Side effects at injection site

What to track weekly

• Resting heart rate and HRV if you wear a tracker
• Frequency of minor infections over the season
• Recovery from training
• Body weight

Bloodwork worth doing

If you have access:

• CBC with differential (lymphocyte subsets if available)
• CRP
• Vitamin D
• Fasting glucose and HbA1c as general health context

Baseline before the course, then 4 to 6 weeks after the course ends. A single mid-course draw rarely tells you much.

Realistic expectations

The honest version: most self-experimenters running Thymalin will not see dramatic short-term changes. The published claims sit in immune regulation over months, not next-week energy boosts. If your goal is "feel better tomorrow," this is the wrong peptide.

Common mistakes

• Treating it like a daily peptide. It is structured as short courses, not chronic dosing.
• No baseline. Without 2 to 4 weeks of pre-course tracking, you cannot see what changed.
• Stacking with three other peptides at once. You will not be able to attribute anything.
• Ignoring infection frequency. The most plausible outcome metric is fewer or shorter colds across a season — and that requires patient logging.

A tracking template

• Weeks minus 4 to 0: baseline daily metrics, no peptide
• Course 1: 10 days on, daily log
• Weeks 2 to 12: off, continue daily tracking
• Course 2: repeat
• Compare seasonal infection counts year-over-year in Peptide IA

Safety notes

Thymus extracts can vary widely in purity and composition depending on source. Source quality matters more here than for synthetic peptides. Discuss with a physician, particularly if you have autoimmune disease, are immunosuppressed, or are on immune-modulating medications.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.